00000000nam 2200000za 4500
0019.845494
003CaOODSP
00520221107153000
007cr |||||||||||
008171013s2017    oncd    ob   f000 0 eng d
040 |aCaOODSP|beng
043 |an-cn---
0861 |aYN5-127/2017E-PDF
1001 |aBusby, Carleigh.
24510|aFederal cost of a national pharmacare program |h[electronic resource].
260 |aOttawa : |bOffice of the Parliamentary Budget Officer, |c2017.
300 |a88 p. : |bcol. charts
500 |aIssued also in French under title: Coût d’un programme national d’assurance-médicaments de régie fédérale.
500 |aCover title.
500 |a"28 September 2017."
500 |aWritten by: Carleigh Busby. Cf. p. [3] of cover.
504 |aIncludes bibliographical references.
520 |a“In September 2016, the House of Commons Standing Committee on Health asked the Parliamentary Budget Officer (PBO) to provide a cost estimate of implementing a national Pharmacare program. The Committee provided the program’s framework, including the inclusive list of drugs to be covered by Pharmacare based on Quebec’s formulary, eligibility requirements, co-payment levels, and eligibility requirements for co-payment exemptions. This paper estimates the cost to the federal government of implementing this particular framework for Pharmacare. It incorporates PBO’s assumptions of the potential savings resulting from a stronger position for drug price negotiations, consumption or behavioural responses of providing coverage, and potential changes in the drug market composition. In addition, this paper provides five-year projections of these federal costs. However, the costs associated with a single administrator of drug benefit claims when compared to multiple administrators both public and private are not considered"--Executive summary, p. 1.
69207|2gccst|aDrug insurance
69207|2gccst|aCosts
7101 |aCanada. |bOffice of the Parliamentary Budget Officer.
77508|tCoût d’un programme national d’assurance-médicaments de régie fédérale |w(CaOODSP)9.845496
85640|qPDF|s993 KB|uhttps://publications.gc.ca/collections/collection_2017/dpb-pbo/YN5-127-2017-eng.pdf